PROVIDER PROFILE · NPI 1790715365

Juan ParamoMD

Hematology-OncologyMiami Beach, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

304

Unique beneficiaries

—

Total services

341

Distinct HCPCS

Medicare payment

$37K

Peer benchmark

Total Medicare services vs. 737 Hematology-Oncology providers in FL — bottom quintile (cohort median 1,932).

PRESCRIBING · PART D · 2024

Total Rx claims

134

Beneficiaries

—

Total drug cost

$560

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Tramadol Hcl72 claims

Levothyroxine Sodium62 claims

QUALITY · MIPS · 2024

Final MIPS score

93.8

Quality

80.4

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.79%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$443

Payment records

By payment type

Food and Beverage$433

Travel and Lodging$10

REFERRAL NETWORK

Where Juan Paramo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Stuart Kaplan Diagnostic Radiology · Sunrise, FL	37	104
Chetan Rajadhyaksha Diagnostic Radiology · Miami, FL	29	79
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	27	74
Katrina Rabinovich Diagnostic Radiology · Miami Beach, FL	22	32
William Burke Diagnostic Radiology · New York, NY	14	40
Jose Lutzky Hematology-Oncology · Miami, FL	13	78

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history